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Abstract
Neuronal calcium sensor-1 (NCS-1) is a Ca
2+ sensor protein that has been implicated in the regulation of various aspects of
neuronal development and neurotransmission. It exerts its effects through interactions with a range of target proteins one
of which is interleukin receptor accessory protein like-1 (IL1RAPL1) protein. Mutations in IL1RAPL1 have recently been
associated with autism spectrum disorders and a missense mutation (R102Q) on NCS-1 has been found in one individual
with autism. We have examined the effect of this mutation on the structure and function of NCS-1. From use of NMR
spectroscopy, it appeared that the R102Q affected the structure of the protein particularly with an increase in the extent of
conformational exchange in the C-terminus of the protein. Despite this change NCS-1(R102Q) did not show changes in its
affinity for Ca
2+ or binding to IL1RAPL1 and its intracellular localisation was unaffected. Assessment of NCS-1 dynamics
indicated that it could rapidly cycle between cytosolic and membrane pools and that the cycling onto the plasma
membrane was specifically changed in NCS-1(R102Q) with the loss of a Ca
2+ -dependent component. From these data we
speculate that impairment of the normal cycling of NCS-1 by the R102Q mutation could have subtle effects on neuronal
signalling and physiology in the developing and adult brain.
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Introduction
Calcium has effects on multiple aspects of neuronal function
through the action of Ca
2+-sensor proteins. The Neuronal
Calcium Sensor (NCS) proteins are a family of such proteins that
are predominantly expressed in neurones and are characterised by
their structural similarities and a high (low micromolar) affinity for
Ca
2+ [1]. Each NCS protein contains four EF-hand Ca
2+-binding
domains of which 2–3 have the capacity to bind Ca
2+, and many
are N-terminally myristoylated [2]. Different NCS proteins can
regulate distinct target proteins, and they can have highly specific,
or more wide-ranging, distributions and cellular roles [1].
NCS-1 is the most conserved of the NCS protein family, with an
orthologue, Frq1, found in yeast [3]. In multicellular organisms, it
has multiple binding partners [4] and is involved in a range of
cellular processes, though in broad terms, it has been most
associated with central nervous system development and with
neurotransmission. A role in development may be inferred from its
regulation of neurite outgrowth and synapse formation, which has
been seen in flies, molluscs, birds and mammals [5,6,7,8,9,10,11].
The likely importance of NCS-1 in complex and highly specialised
developmental programs is suggested by studies showing that its
transcription is under the control of homeobox and patterning
genes in C. elegans, and that its expression is required for
formation of the semicircular canals in zebrafish [12,13,14]. The
involvement of NCS-1 in neurotransmission has been charac-
terised in several systems [15,16]. A recent knockout study in flies
indicates that it is important in regulating presynaptic calcium-
influx [17] and its over-expression has been shown to enhance
short term potentiation [18], its expression is increased in long
term potentiation [19,20], and it is thought to be necessary for at
least one form of long term depression [21]. Consistent with the
suggestion that its effects on synaptic plasticity are relevant to
central nervous system function, associative learning and memory
is disrupted when NCS-1 is absent in C. elegans, and enhanced
when it is over-expressed [22]. Furthermore, selective moderate
over-expression of NCS-1 in the dentate gyrus of mice has recently
been found to promote rapid acquisition of spatial memory [23].
Amongst the proteins that interact with NCS-1 is interleukin
receptor assessory protein like-1 (IL1RAPL1) [24]. This is a
transmembrane protein found mostly in the brain, and in
particular in the hippocampus [25]. The protein contains three
extracellular immunoglobulin-like domains, an intracellular Toll/
Interleukin receptor domain and a specific domain [24]. It was
found that part of the specific domain can bind to NCS-1 and this
interaction may mediate the down-regulation of N-type calcium
channels [24,26]. Like NCS-1, IL1RAPL1 has been implicated in
nervous system development [27], and in particular in neurite
outgrowth and differentiation [26,28]. The gene encoding
IL1RAPL1 is on the X chromosome, and has been found to be
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[25,29,30,31,32], and polymorphisms in the gene have been
associated with differences in human cognition [33]. In a recent
study, linkage analysis has suggested an association between loss of
function mutations in the gene encoding IL1RAPL1 and a number
of cases of familial autism and autistic spectrum disorder (ASD)
[34]. Females carrying a loss of function mutation in IL1RAPL1
were found to exhibit a spectrum of phenotypes ranging from no
obvious impairment to autism with or without mild mental
retardation. Males with such a mutation were found to have mild
to severe autism, mental retardation or both. In the same study a
screen was also carried out on a cohort of 142 patients with ASD
and 190 control subjects for mutations in NCS-1. Exon 4 of NCS-
1 was not found to be mutated in any of the control subjects, but a
point mutation, NCS-1(R102Q), was identified in one individual
with ASD [34]. It is not known, however, whether there is any
causal relationship between this amino acid change and ASD or
whether instead this represents a polymorphism in the Jewish
Sefrade population to which the subject belonged.
In previous studies linking NCS-1 to disease states [35], it has
been found that expression of NCS-1 is elevated in the prefrontal
cortices of patients with schizophrenia and bipolar disorder
[36,37], and is up-regulated in injured neurones and in epilepsy
[38,39]. NCS-1 has, however, previously only been speculatively
associated with MR and ASD on the basis of its interaction with
IL1RAPL1 [26,34]. Furthermore, it is unclear whether the
R102Q mutation/polymorphism in NCS-1 found in a single
individual would have any consequences for NCS-1 function. In
this study, we present evidence for structural and functional
deficits in NCS-1(R102Q) suggesting that this mutation could
indeed have pathological consequences.
Results
NMR spectroscopy identifies a structural deficit in NCS-
1(R102Q)
On the basis of the published crystal structure of NCS-1 [40],
the NCS-1(R102Q) mutation affects an exposed surface residue
that forms part of an a-helix spanning residues 98–108 (helix F).
Use of the AGADIR tool [41] predicted that this sequence has a
high propensity to form a helix, in fact the highest compared to the
rest of the NCS-1 polypeptide sequence. Interestingly the R102Q
mutation reduced the a-helical propensity of surrounding sequence
by approximately four-fold (Table S1). In order to determine
whether this prediction was reflected in terms of altered protein
structure, 2-D
1H/
15N heteronuclear single quantum coherence
(
1H/
15N HSQC) NMR spectra were acquired for the wild-type
and mutant proteins. Unmyristoylated,
15N-labeled NCS-1 and
NCS-1(R102Q) were prepared and spectra collected for the Ca
2+
loaded samples. Resonance assignments of the
1H/
15N HSQC
spectrum of wild-type NCS-1 were made through comparison to
published data [42] on unmyristoylated Ca
2+ loaded NCS-1
(Biological Magnetic Resonance Data Bank accession number
4378). Resonances corresponding to all amino acid residues were
assigned, with the exception of N-terminal residues 1–5, which are
unstructured [42] (Figure 1A, black peaks). For NCS-1(R102Q),
1H/
15N HSQC spectra resonances corresponding to the majority
of residues coincided with those found in the spectrum of the wild
type protein, indicating that most of the mutant is structurally
identical to wild type protein (see Figure 1A, red). Strikingly
however, a number of resonances were shifted or showed a
dramatic reduction in intensity, and several were entirely absent
(see examples in Figure 1, B–C and D–E respectively) indicating a
substantial conformational exchange in the mutant protein.
Figure 2A shows a plot of the positions of shifted and ‘lost’
resonances from the
1H/
15N HSQC spectra of NCS-1(R102Q)
with respect to NCS-1 amino acid sequence. Resonance changes
were seen throughout the polypeptide sequence with the number
of changes more marked around the site of mutation in helix F
(residues 99–109). Interestingly, many of the chemical shift
perturbations also occurred at the C-terminus with the resonances
of 10 of the C-terminal 21 residues being undetectable in the
1H/
15N HSQC spectrum of NCS-1(R102Q). It appears that the
R102Q mutation has given rise to long-range effects, leading to an
increase in the dynamics of the C-terminus region. These residues
correspond to a region in the crystal structure that is stabilised by
hydrogen bonding [40] to helix F carrying the mutation. We
speculate that the Arg to Gln mutation at position 102 perturbs the
helical stability of helix F; this in turn disrupts the hydrogen-
bonding network shown in Figure 2B, leading to the C-terminus
region being structurally less constrained. The extreme line-
broadening observed in the NMR spectrum for the C-terminus
region is due to the resultant conformational exchange. It is
possible to rule out C-terminus proteolysis since, firstly, peaks
corresponding to some C-terminal residues remained (see
Figure 1B), secondly, the recombinant protein samples used
in the NMR spectroscopy were indistinguishable in size in the
SDS –PAGE gels (see Figure 2C), and thirdly, mass spectrometry
confirmed that both proteins were full-length with no evidence of
truncations.
NCS-1 and NCS-1(R102Q) possess comparable
Ca
2+-sensitivity in vitro
Having shown that the R102Q mutation affected the structure
of NCS-1 we explored the possibility that it might affect the Ca
2+-
binding characteristics of the protein. We used changes in intrinsic
tryptophan fluorescence to report the conformational change in
NCS-1 and NCS-1(R102Q) in response to Ca
2+ binding, as this
approach has been successfully used previously [43,44,45,46].
Proteins were excited with 280 nm light, and emission spectra
from 290 nm to 410 nm were recorded as free Ca
2+ concentra-
tions in the buffer were incrementally increased. Saturating
concentrations of free Mg
2+ were present in the buffer to insure
that this ion did not influence the results [44]. As in previous
studies, it was found that NCS-1 fluorescence peaked at 340 nm in
the absence of Ca
2+ (see Figure 3 A). Increasing free Ca
2+ up to
0.06 mM caused a slight increase in peak height, while its further
increase led to a fall in peak height, and a shift in peak fluorescence
to around 337 nm (see Figure 3A,B).
Peak NCS-1(R102Q) fluorescence did not fall to the same
extent, but this may be because one of the only two tryptophan
residues in NCS-1(R102Q), W103, is in a position adjacent to the
mutated residue. Importantly, changes in wild-type and mutant
NCS-1 fluorescence followed a similar pattern, suggesting that the
proteins underwent conformational change at the same Ca
2+
concentration (see Figure 3C).
The R102Q mutation does not affect binding of NCS-1 to
IL1RAPL1 In vitro
Interestingly, the C-terminal region identified by NMR as altered
in NCS-1(R102Q) corresponds almost exactly to the minimal NCS-
1(174–190) domain required for its binding to IL1RAPL1 [24].
Experiments were therefore carried out to determine whether the
mutation affected the interaction between NCS-1 and the NCS-1-
binding domain of IL1RAPL1 in vitro. GST and GST-IL1-
RAPL1(569–644) were immobilised on glutathione-Sepharose
beads, and incubated with recombinant NCS-1 or NCS-1(R102Q)
Analysis of NCS-1 Mutant
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Specific binding of NCS-1 and the mutant to GST-IL1RAPL1(569–
644) was observed. In contrast to a previous report [24], interaction
between GST-IL1RAPL1(569–644) and NCS-1 was only detected
in the presence of Ca
2+ and at similar Ca
2+ concentrations to those
where changes in tryptophan fluorescence occurred. However, in
five separate experiments, no consistent differences between the
binding of NCS-1 and NCS-1(R102Q) to GST-IL1RAPL1(569–
644) were identified nor were any differences in Ca
2+-dependency
observed. In a separate experiment to quantify binding to GST-
IL1RAPL1(569–644), the level of binding of NCS-1(R102Q) was no
different (97.364.9%, n=4) from that for wild-type NCS-1 at 1 mM
free Ca
2+ concentration after correction for levels of input protein
(Figure S1).
Exogenous NCS-1 and NCS-1(102Q) localise identically in
N2A cells, and partially colocalise with exogenous
IL1RAPL1
Since no functional differences between NCS-1 and NCS-
1(R102Q) proteins were identified In vitro, it was decided to
Figure 1. The R102 mutation modifes the
1H/
15N HSQC spectrum of NCS-1. (A) Overlay of the
1H/
15N HSQC spectra of wild type NCS-1
(black) and NCS-1(R102Q) (red). Residues assigned in the wild type NCS-1 are shown by residues number. (B–D) Examples of expanded regions of the
overlaid spectra showing resonances that overlap, are shifted or absent in NCS-1(R102Q) compared to wild type protein.
doi:10.1371/journal.pone.0010534.g001
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Since the NMR data indicated that the R102Q mutation affected
the IL1RAPL1-binding domain of NCS-1, and since we had not
ruled out the possibility of a cellular effect on the NCS-1-
IL1RAPL1 interaction, we chose to use cells that endogenously
express both NCS-1 and IL1RAPL1 in this study. Previous studies
on NCS-1 and IL1RAPL1 have been conducted using PC12 cells,
but endogenous expression of IL1RAPL1 has not been detected in
these cells [24,26]. We therefore identified mouse N2A neuro-
blastoma cells as expressing both proteins (Figure S2), and
characterised NCS-1 localisation in this cell line.
NCS-1 associates with the plasma membrane and Golgi
complex as a result of its N-terminal myristoylation [47,48].
Exogenously expressed fusion proteins of NCS-1, containing a
C-terminal GFP-variant moiety, correctly localise to the Golgi
complex and plasma membrane in various cell types, and
appear to colocalise at the Golgi with known NCS-1 binding
partners including ARF-1 and PI4KIIIb [49,50,51,52]. How-
ever, when we compared the localisation of NCS-1-mCherry to
that of PI4KIIIb-ECFP in N2A cells, we identified only partial
colocalisation in the perinuclear region (Figure 4, A–C). It has
been suggested that NCS-1 and the small GTPase ARF-1
Figure 2. The C-terminus of NCS-1 is particularly affected by the R102Q mutation. (A) Distribution of resonances along the NCS-1 sequence
that are the shifted or undetectable in the NCS-1(R102Q)
1H/
15N HSQC spectrum. (B) Structure of the C-terminal half of NCS-1 (residues 93–186
rendered from the PDB file1G8I) showing the position of R102 within helix F and the hydrogen bond interactions between helix F and the C-terminal
domain. (C) Coomassie blue-stained SDS-polyacrylamide gel showing the NCS-1 and NCS-1(R102Q) proteins after analysis by NMR spectroscopy.
doi:10.1371/journal.pone.0010534.g002
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Supporting this view, we found that ARF-1-EGFP colocalised
with PI4K-ECFP (Figure 4 D–F) but ARF-1-EGFP poorly with
N C S - 1 - m C h e r r y( s e eF i g u r e4 ,G – I ) .O u ri n t e r p r e t a t i o no f
these data is that NCS-1 and its binding partners adopt
discrete but overlapping localisations, and that NCS-1 localises
to a specific Golgi subdomain in N2A cells. To characterise the
localisation of NCS-1 at the Golgi complex, NCS-1-ECFP was
compared to two Golgi markers. In live cell experiments, it
was found that NCS-1-ECFP was colocalised poorly (Figure 4
J–L) with a Golgi-YFP (1,4-galctosyltransferase(1-81)-YFP)
which is targeted to the cis-Golgi. To label the trans-Golgi
network (TGN), we transfected cells with a fluorescent variant
of the viral cargo protein VSVG, and used a 20uC
temperature-block to prevent its exit from the TGN. Cotrans-
fected NCS-1-ECFP colocalised well with this protein at the
Golgi (Figure 4, M–O), suggesting that it associated with the
membranes of the TGN.
To identify any difference in the localisation of NCS-1 and
NCS-1(R102Q), N2A cells were alternately cotransfected with
NCS-1-ECFP and NCS-1(R102Q)-mCherry, and NCS-
1(R102Q)-ECFP and NCS-1-mCherry. When the lysates from
individually transfected wells were subjected to SDS-PAGE
and Western blotting, and the blots were probed with an
Figure 3. The R102Q mutation does not affect binding to IL1RAPL1 or Ca
2+-binding. (A,B) The endogenous tryptophan fluorescence of
NCS-1 and NCS-1(R102Q) was monitored by excitation at 280 nm and scanning over a range of emission wavelengths before and after step-wise
addition of CaCl2 to give the indicated free Ca
2+ concentrations. (C) The peak emission value for each emission trace was determined, normalised to
the overall peak value for that experiment and the data expressed as the mean 6 SEM (n=10) for each free Ca
2+ concentration tested. (D) NCS-1 and
NCS-1(R102Q) were incubated with GST or GST-IL1RAPL1(569–644) in the absence or presence of the indicated free Ca
2+ concentrations.
doi:10.1371/journal.pone.0010534.g003
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expressed at the same levels (Figure 5A) indicating no
differences in the stability of the two proteins. When
coexpressing cells were imaged, the NCS-1 and NCS-1
(R102Q) fusions were found in the same localisations at the
plasma membrane and the TGN of cells (Figure 5, B–D and E–
G). We also compared the localisation of NCS-1 and NCS-
1(R102Q)-mCherry with IL1RAPL1-GFP. The co-localisation
between NCS-1 and NCS-1(R102Q)-mCherry in the perinu-
clear region was partial but both colocalised similarly with
I L 1 R A P L 1 - G F Pa tt h ep l a s m am e m b r a n e( s e eF i g u r e5H – J
and K–M).
Over-expression of NCS-1 and NCS-1(R102Q) similarly
affects Ca
2+ signalling in N2A cells
As we had identified no deficits in NCS-1(R102Q) calcium-
binding in vitro, or in its localisation in N2A cells, we proceeded to
examine whether the mutation might affect the capacity of NCS-1
to modulate intracellular Ca
2+ signalling. The involvement of
NCS-1 in Ca
2+ signalling is complex, as it has been suggested to
act via various target proteins. It has been reported to interact with
InsP3 receptors, and to enhance their activity in a Ca
2+-dependent
manner [53]. It has also been reported to either positively or
negatively regulate P/Q-type voltage-gated Ca
2+ channels
(VGCCs), and to be required for the negative regulation of
Figure 4. Localisation of exogenously expressed NCS-1 in N2A cells. N2A cells were transfected to express the indicated constructs and live
cells were imaged using confocal microscopy. For the colour overlays (C,F,I,L,O) the images in A,D,G,J and M are in green and those in B,E,H,K,N are in
red with co-localisation appearing in yellow. All images were taked form live cells except for those expressing VSVG-GFP which were fixed after
transfection and incubation overnight at The scale bars represent 10 mm.
doi:10.1371/journal.pone.0010534.g004
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may regulate channels either directly, or by influencing phospho-
inositide signalling or membrane trafficking [49,56]. In order to
raise intracellular Ca
2+ in the present study, we used the SERCA
pump inhibitor thapsigargin to release Ca
2+ from the endoplasmic
reticulum followed by Ca
2+ addition to the external medium to
determine general effects of NCS-1 over-expression on Ca
2+
release and entry. N2A cells were examined in a protocol in which
they were exposed to 1 mM thapsigargin in the absence of
extracellular Ca
2+ in order to release calcium from internal stores,
and then extracellular Ca
2+ was added to a concentration of
3 mM in order to provoke store-operated calcium entry. The
resulting changes in intracellular Ca
2+ concentration were
monitored using the Ca
2+ indicator Fluo-4, and the responses of
untransfected and transfected cells in the same dishes were directly
compared. No significant difference was identified between the
responses of untransfected cells and cells transfected to express
mCherry as a control, and in both cases, there was an initial
increase in intracellular Ca
2+ concentration after addition of
thapsigargin, and this was followed by a larger rise in intracellular
Ca
2+ concentration after addition of extracellular Ca
2+ (Figure 6A).
In contrast, when the responses of cells transfected to express
either NCS-1-mCherry or NCS-1(R102Q)-mCherry were com-
pared to those of untransfected controls, differences were observed
(Figure 6). Expression of NCS-1-mCherry or NCS-1(R102Q)-
mCherry led to a reduction in the rate of increase in Ca
2+ levels
following thapsigargin treatment and also following addition of
extracellular Ca
2+ (Figure 6B,C). There was, however, no
significant difference in the overall changes in intracellular Ca
2+
concentration between cells expressing each of the two NCS-1
constructs.
NCS-1 and NCS-1(R102Q) associate dynamically with
cellular membranes
Previous work has shown that unlike the situation with a
number of other NCS family members, the myristoyl group of
NCS-1 is continually exposed, and NCS-1 is membrane-
associated, at resting Ca
2+ concentrations [47]. However, it has
also been reported that ,30% of cellular NCS-1 is cytosolic
[16,57]. This raises the possibility that NCS-1 cycles between
membrane-associated and cytosolic states even at resting Ca
2+
concentrations, and only interacts with membranes transiently.
This possibility has not, however, been investigated. In order to
establish whether NCS-1 associates with membranes in a transient
or a stable manner, fluorescence loss in photobleaching (FLIP)
experiments were carried out. The rationale behind this technique
Figure 5. NCS-1 and NCS-1(R102Q) are similarly expressed and localised in N2A cells. N2A cells were transfected to express the indicated
constructs and live cells were imaged using confocal microscopy. (A) Western blot of cells with anti-GFP showing protein expressed from a control
EGFP vector, or plasmids encoding NCS-1-EGFP or NCS-1(R102Q)-EGFP. (B–M) For the colour overlays (D,G,J,M) the images in B, E, H, and K are in
green and those in C,F, I, and L are in red with co-localisation appearing in yellow. The scale bars represent 10 mm.
doi:10.1371/journal.pone.0010534.g005
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transiently with membranes, progressive bleaching of the cytosolic
pool leads to parallel loss of cytosolic and membrane fluorescence.
Whereas, when a protein is more stably associated with
membranes, membrane fluorescence is lost at a much slower rate.
Parts A and B of Figure 7 show FLIP data from cells expressing
EGFP-labelled wild-type or NCS-1(R102Q). The aim of this
experiment was primarily to compare the bleaching times for
cytosol, Golgi and plasma membrane for each protein. The cells
expressing wild type and mutant proteins were analysed on
different days and so the bleaching rates for each protein cannot
be directly compared between Figure 7A and 7B. As seen in
Figure 7, repetitive bleaching of either NCS-1- or NCS-1(R102Q)-
EGFP within a region of the cytosol led to loss of Golgi- and
plasma membrane-associated fluorescence that paralleled the loss
of cytosolic fluorescence in each case. These data indicate that
these proteins must interact with membranes transiently and
rapidly exchange between cytosolic and membrane pools.
To compare the dynamics of NCS-1- and NCS-1(R102Q)-
membrane interactions at the TGN in more detail, fluorescence
recovery after photobleaching (FRAP) experiments were conduct-
ed. The small GTPase ARF-1, which has also been shown to
interact with Golgi membranes in a transient manner [58] was
used as a positive control in these experiments. In a FRAP
experiment, the fluorescent protein within a small region of
interest (ROI) of a cell is bleached using a high-intensity laser, and
the recovery of fluorescence within this area is subsequently
monitored [59]. The recorded fluorescence recovery reflects the
replacement of bleached protein in the ROI with unbleached
protein from outside this region. The data in Figure 7, C and D,
derives from the bleaching of circular regions of the Golgi of 2 mM
diameter and monitoring of the fluorescence recovery. ARF-1-
EGFP recovery was best fit by one-phase association kinetics with
its recovery reaching a plateau at 95.9760.14% and a recovery
halftime of 17.29s. Fluorescence recovery of NCS-1-EGFP and
NCS-1(R102Q)-EGFP was rapid and almost complete, and their
recovery profiles were nearly superimposable. Non-linear regres-
sion analysis indicated that recovery was better fit by two-phase
than by one-phase association kinetics (p,0.0001), and that
recovery reached a plateau at 98.1360.06 and 97.7960.09%,
with halftimes calculated as 0.55 s and 4.65 s, and 0.58 s and
7.19 s, for NCS-1 and NCS-1(R102Q) respectively. Taken
together these data from both FLIP and FRAP experiments
suggest that both the wild type and mutant NCS-1 proteins
interact with membranes transiently, and if this interpretation is
correct then it appears that they cycle on and off membranes more
rapidly than ARF-1.
Ca
2+ elevation differentially affects NCS-1 and NCS-
1(R102Q) dynamics at the plasma membrane
It was important to continue characterisation of the association/
dissociation kinetics of NCS-1 and NCS-1(R102Q), as although
the kinetics were no different at the TGN, some of the functions of
NCS-1 are restricted to the plasma membrane. FRAP was used to
assess the dynamics of NCS-1 and NCS-1(R102Q)-EGFP. In these
experiments, cells expressing each of the proteins were tested on
the same day with measurements alternating between wild-type
and mutant expressing cells so that the data for each protein could
be directly compared. Upon examination of plasma membrane
association/dissociation kinetics, it was found that the recovery of
NCS-1-EGFP and NCS-1(R102Q)-EGFP fluorescence differed
(Figure 8 A,B).
Under resting conditions, recovery was fast with both proteins
and best fit by two-phase association kinetics, but while NCS-1-
EGFP fluorescence recovered with halftimes of 1.64 s and 14.23 s,
NCS-1(R102Q)-EGFP fluorescence recovered with halftimes of
1.11 s and 6.27 s (Figure 8C). While the recovery of NCS-1-EGFP
plateaued at 98.8560.06% that of NCS-1(R102Q)-EGFP pla-
Figure 6. Expression of NCS-1 or NCS-1(R102Q) has similar
inhibitory effects on intracellular Ca
2+ signals in N2A cells. N2A
cells were transfected to express mCherry from a control vector (A),
NCS-1-mCherry (B) or NCS-1(R102Q)-mCherry (C) and loaded with the
Ca
2+ indicator Fluo4. Changes in Fluo4 fluorescence were monitored
over time following addition of 1 mM thapsigargin in the absence of
extracellular Ca
2+ and subsequent addition of 3 mM Ca
2+ to the
external medium. Fluorescence values were expressed as a ratio of the
starting fluorescence value for each cell and are shown as mean 6 SEM
(n=49261 cells per condition). In each experiment Fluo4 fluorescence
was monitored in transfected and adjacent untransfected cells in the
same microscope fields for direct comparison.
doi:10.1371/journal.pone.0010534.g006
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tion, these data suggest that a portion of NCS-1(R102Q)-EGFP is
not replaced by unbleached protein following photobleaching, but
is retained in the bleached region.
Reports conflict as to whether calcium elevation causes NCS-1
translocation to the plasma membrane. While no change was
identified in NCS-1 localisation by conventional confocal
microscopy upon an increase in intracellular calcium [47], NCS-
1 is more strongly associated with membrane fractions prepared in
the presence of calcium than with fractions prepared in its absence
[16,57]. This discrepancy may be explained, if NCS-1 is
transiently membrane associated under resting conditions, but a
fraction of the protein becomes more stably associated on Ca
2+
elevation. In order to test this hypothesis, we conducted parallel
bleaching experiments on cells transfected to express the NCS-1
constructs in the presence or absence of 1 mM thapsigargin. We
used this reagent to raise intracellular Ca
2+ since we had already
demonstrated that it produces comparable, long-lasting calcium
elevations in cells expressing NCS-1-EGFP or NCS-1(R102Q)-
EGFP (Figure 7). As compared to the calculated association
kinetics in untreated cells expressing NCS-1-EGFP, we found that
in the presence of thapsigargin, the fast phase of association was
not significantly altered, but that the slow phase of association was
affected (Figure 8A,C). Furthermore, fluorescence recovery
reached plateau at a lower level in the treated cells
(94.660.06% compared to 98.8560.0.07%). In contrast we found
that thapsigargin treatment had no significant effect on the
fluorescence recovery profile of NCS-1(R102Q)-EGFP (Figure 8B).
We conclude that while wild-type NCS-1 is stabilised at the plasma
membrane upon elevation of intracellular Ca
2+ concentration, the
R102Q mutant protein is already partly deficient in its capacity to
dissociate from the plasma membrane under resting conditions
and so elevated Ca
2+ does not affect its dynamics.
Discussion
The data presented in this paper provide insights into the
cellular localisation and dynamics of NCS-1 and describe
structural and functional deficits in the R102Q mutation/
polymorphism of NCS-1 that had been discovered in an individual
Figure 7. NCS-1 and NCS-1(R102Q) associate dynamically with the plasma membrane and TGN in N2A cells. (A) Cells transfected to
express NCS-1-EGFP were treated in a FLIP protocol in which a small region of the cytosol was repetitively photobleached and fluorescence was
monitored in regions of the cytosol, plasma membrane and Golgi complex. Data are shown as mean 6 SEM (n=8 cells). Fluorescence declined in all
three regions with the same time course. (B) Cells transfected to express NCS-1(R102Q) -EGFP were treated in the FLIP protocol. Data are shown as
mean 6 SEM (n=14 cells). Fluorescence declined in all three regions with the same time course. (C) Cells transfected to express ARF1-EGFP were
subjected to a FRAP protocol in which a region of interest over the Golgi complex was photobleached and the recovery of fluorescence in the same
region was monitored over time. Data are shown as mean 6 SEM (n=9 cells). The curve shows the data fitted using non-linear regression to one
phase recovery kinetics. (D) Cells transfected to express NCS-1-EGFP or NCS-1(R102Q)-EGFP were subjected to a FRAP protocol in which a region of
interest over the Golgi was photobleached and the recovery of fluorescence in the same region was monitored over time. Data are shown as mean 6
SEM (n=12 cells per condition). The curves shows the data fitted using non-linear regression to two phase recovery kinetics.
doi:10.1371/journal.pone.0010534.g007
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compare the
1H/
15N HSQC spectra of recombinant NCS-1 and
NCS-1(R102Q). The
1H/
15N HSQC spectrum of the mutant
protein showed a number of resonances from residues towards the
C-terminus which are either absent or significantly reduced in
intensities when compared to the spectrum of the wild-type
protein. The mutation of this single surface residue appeared to
have produced pronounced, long-range as well as local changes. It
is interesting to note that while R102 is not conserved in lower
organisms such as C. elegans and Drosophila, it is conserved in all
species from fish to man. The AGADIR analysis predicts a
reduction in helical content in helix F when R102 is mutated to a
glutamine. Therefore, it is most likely that the destabilisation of
helix F affects the hydrogen-bond network which in the wild-type
protein restraints the conformational dynamics of the C-terminus
region. A result of this hydrogen bond perturbation is that the C-
terminus is able to adopt several conformations which are in
chemical exchange. Despite these structural changes in NCS-
1(R102Q), the protein shows a Ca
2+-dependent conformation
change as monitored by tryptophan fluorescence at the same Ca
2+
concentration as wild type protein, localised essentially identically
to wild-type NCS-1 when expressed in N2A cells and had a similar
effect on thapsigargin-induced Ca
2+ signals.
The localisation of exogenous NCS-1 in N2A cells that we
identified in this study is similar to that seen in other cell types in
previous studies [47,49,50,51,52]. However, the localisation of
NCS-1 with respect to the Golgi complex had not previously been
examined in detail, and in this study we show that NCS-1
preferentially associates with a subdomain of the Golgi, the TGN,
but not with cis-regions of the Golgi. Previous work, based on
steady-state imaging, was interpreted as showing that a substantial
proportion of NCS-1 was stably membrane-associated through its
N-terminal myristoyl tail in resting cells 1[47]. However, other
partly cytosolic peripheral proteins, such as GTP-binding proteins
[58,60,61], are known to cycle between membranes and cytosol,
and an increase in NCS-1 membrane association is reported in
response to cellular Ca
2+ elevation [57,62]. The dynamics of
cycling can be assessed using analysis of FRAP. Evidence of
recovery of membrane fluorescence in FRAP experiments could
be due to either exchange of the fluorescent protein between
membrane and cytosolic pools or to rapid mobility of the protein
in the membrane. We have found using FLIP, however, that
photobleaching of the cytosol resulted in a parallel loss of NCS-1-
and NCS-1(R102Q)-EGFP fluorescence on the Golgi and plasma
membranes. This finding can only be explained by rapid cycling
between membrane and cytosolic pools and suggests that the
association of NCS-1 and R102Q with the TGN and the plasma
membrane is highly dynamic under resting conditions. From
FRAP experiments, it was observed that Ca
2+ elevation stabilises a
fraction of cellular NCS-1 at the plasma membrane. Presumably,
this stabilisation follows Ca
2+ -binding by NCS-1 and possibly
Ca
2+-dependent interaction with a binding partner. It has been
previously shown that bradykinin stimulation, which raises
intracellular Ca
2+ via IP3 -induced calcium release, can shift a
proportion of cellular NCS-1 into detergent resistant plasma
membrane microdomains [63] and it is possible that a calcium-
dependent protein-protein interaction drives this relocation.
While the major structural changes in NCS-1(R102Q) were in the
domain required for binding to IL1RAPL1, the main functional
effect of the mutation was loss of a Ca
2+-dependent component of
Figure 8. The dynamics of NCS-1 and NCS-1(R102Q) at the
plasma membrane in N2A cells and the effects of elevation of
intracellular Ca
2+ differ. (A) Cells transfected to express NCS-1-EGFP
were subjected to a FRAP protocol in which a region of interest over the
plasma membrane was photobleached and the recovery of fluores-
cence in the same region was monitored over time. Cells were either
untreated or were exposed to 1 mM thapsigargin in the presence of
3 mM external Ca
2+. Data are shown as mean 6 SEM (n=34 and n=36
for control and thapsigargin-treated cells respectively. The curves
shows the data fitted using non-linear regression to two phase recovery
kinetics. (B) Cells transfected to express NCS-1(R102Q)-EGFP were
subjected to a FRAP protocol in which a region of interest over the
plasma membrane was photobleached and the recovery of fluores-
cence in the same region was monitored over time. Cells were either
untreated or were exposed to 1 mM thapsigargin in the presence of
3 mM external Ca
2+. Data are shown as mean 6 SEM (n=38 and n=40
for control and thapsigargin-treated cells respectively. The curves
shows the data fitted using non-linear regression to two phase recovery
kinetics. (C) Values for the calculated half-times of recovery from a non-
linear regression analysis based on two-phase association kinetics.
doi:10.1371/journal.pone.0010534.g008
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ity is that in cells, wild type NCS-1 binds to an endogenous plasma
membrane target protein effectively only when Ca
2+ is elevated, but
NCS-1(R102Q) is able to bind to the target protein via its C-
terminus at resting Ca
2+ concentrations. Assay of in vitro binding of
NCS-1 and NCS-1(R102Q) to GST-IL1RAPL1(569–644) did not
reveal any differences, but this may not be surprising, as NCS-1 does
not need to be fully folded to bind to IL1RAPL1. Indeed, the C-
terminus alone, NCS-1(174–190), is sufficient for an interaction
[24]. Use of a C-terminal fragment of NCS-1 as an inhibitory
reagent in cellular studies has suggested the existence of other
important functional interactions through this region of the protein
[7,17,55], but so far only IL1RAPL1 has been shown to bind to this
region of NCS-1 directly.
The functional significance of NCS-1 dynamics and its Ca
2+-
dependent stabilisation at the plasma membrane are not yet clear,
but it is tempting to speculate that the dynamic interaction
between NCS-1 and membranes might allow regulation of its local
levels on neuronal membranes. Impairment of this regulation
could have subtle effects on neuronal signalling and physiology in
developing and adult brain. It is noteworthy that NCS-1 is highly
conserved having an identical amino acid sequence in birds and all
mammals. There are, for example, only four amino acid
differences between NCS-1 in humans and the most similar
NCS-1 in the teleost fish Danio rerio suggesting strong evolutionary
pressure against any changes in its sequence. There is currently
little evidence available for non-synonomous polymorphisms in
NCS-1 in human populations. A direct linkage of the R102Q
mutation/polymorphism to ASD has not yet been established as it
is based on data from a single subject. Further genetic and
functional analysis may now be warranted, however, to determine
the relevance of the R102Q mutation/polymorphism,in NCS-1 to
the pathology of ASD.
Materials and Methods
Plasmids
The NCS-1 sequence was excised from an existing vector [47]
and inserted into pECFP-N1, pEGFP-N1and pmCherry-N1
vectors (Clontech, Basingstoke, UK) to generate mammalian
expression constructs for NCS-1, C-terminally tagged with variant
fluorescent proteins. The fragment encoding NCS-1, and the
target vectors, were generated by digestion with BamHI/XhoI and
were ligated using standard methods. The vector used for the
bacterial expression of GST-NCS-1 was as described previously
[64]. With the above plasmids as templates, NCS-1(R102Q)
plasmids were made by substitution of the 102
nd codon, AGG, for
CAG, using the primer pair 59-GGACCCTGGATGA-
GAAGTTGCAGTGGGCCTTC-39 (sense) and 59-CAACTTC-
TCATCCAGGGTCCCCCTTGAGG-39 (antisense). Mutants
were generated using the GeneTailor system (Invitrogen, Paisley,
UK) according to manufacturer’s instructions. All constructs were
verified by automated sequencing (The Sequencing Service,
Dundee, UK). The Golgi-YFP fusion construct was obtained
from Clontech, and the pIL1RAPL1-GFP [24], pARF1-EGFP
[49], pVSVG-GFP [65], pPI4KIIIb-ECFP [50] and pFAPP1-
EGFP [66] fusion constructs were as described previously. The
plasmid encoding GST-IL1RAPL1(569–644) was prepared by
amplification of the appropriate region from pILRAPL1-GFP and
ligation into pGex-6P-1 (Amersham Biosciences).
Recombinant protein production
GST, GST-IL1RAPL1(569–644), GST-NCS-1 and GST-NCS-
1(R102Q) were expressed in BL21 E.coli. Unlabeled protein was
produced by inoculating SB media, supplemented with 100 mg/l
ampicillin, with single transformed clones, allowing cell growth at
37uC for 15–17 h, and inducing protein expression with 1 mM
isopropyl-b-d-thiogalactopyranoside (IPTG) for 3–4 h.
15N-labeled
GST-NCS-1 and GST-NCS-1(R102Q) were produced by similar
inoculation of M9 minimal media, supplemented with 100 mg/l
ampicillin and containing (
15NH4)SO4 as a sole nitrogen source
with growth at 37uC to a density of 0.8 OD units and induction
with 1 mM IPTG overnight at 30uC. Following cell disruption by
use of a French press, recombinant proteins were purified on
glutathione-conjugated Sepharose. GST tags were removed from
NCS proteins using PreScission protease (Invitrogen) according to
the manufacturer’s instructions prior to use in all experiments.
NMR spectroscopy
The NMR samples of NCS-1 and NCS-1(R102Q) were
approximately 0.5 mM in 20 mM Tris, 50 mM NaCl, 5 mM MgCl2,
10 mm CaCl2,1m MN a N 3 in 90% H2O/10% D2Oa tp H6 . 5 .
Spectra were recorded at 30uC using a Bruker Avance 800 MHz
spectrometer fitted with a triple resonance, single z-axis gradient
cryogenic probehead.
15N-
1H spectra were acquired using water flip-
back pulses. Spectra were processed using Bruker Topspin software.
Binding assays
GST or GST-IL1RAPL1(569–644) was bound to 15 ml
glutathione-Sepharose beads for 1 h at 4uC. Beads were washed
with binding buffer (139 mM NaCl, 20 mM HEPES, 5 mM
EGTA, 5 mM nitrolotriacetic acid, 6.44 mM MgCl2, 1 mM DTT,
pH 7.4) containing CaCl2 to give free calcium concentrations of 0,
0.1, 0.3 or 1 mM, before incubation with 1 mM recombinant NCS-
1 or NCS-1(R102Q) for 1 h at 4uC. The beads were washed three
times in the appropriate buffer, and then bound proteins were
eluted by boiling in SDS/PAGE sample buffer. Samples were
separated by SDS PAGE and proteins were stained using
Coomassie Brilliant Blue. To allow quantification of binding to
IL1RAPL1, multiple binding assays were carried out at 1 mM free
Ca
2+ concentration and samples of bound proteins and input
proteins run on the same gels. Quantification of bound NCS-1
protein was carried out using ImageJ (NIH, Bethesda, Maryland,
USA) and values corrected for concentration of the input proteins.
Spectrofluorometry
To monitor intrinsic tryptophan fluorescence of NCS proteins
[43], purified recombinant NCS-1 or NCS-1(R102Q) at a
concentration of 1 mM in a calcium free buffer (25 mM Tris
HCl, 50 mM KCl, 5 mM EGTA, 5 mM nitrolotriacetic acid,
6.44 mM MgCl2 (2 mM free Mg
2+),1 mM DTT, pH 7.4) were
excited at room temperature with 280 nm light, and their emission
spectra from 290–410 nm were measured, using a Jasco FP-6300
spectrofluorometer (Tokyo, Japan). The concentration of free
calcium was increased by incremental addition of CaCl2 to give
calculated free Ca
2+ concentrations, and additional emission
spectra were measured as before.
Cell culture and transfection
Adherent N2A cells (American Type Culture Collection.
Manassas, Virginia, USA) were grown in 75 cm
2 culture flasks
at 37uC, 5% CO2 in Dulbecco’s Modified Eagle Medium (Gibco,
Paisley, UK) supplemented with 10% foetal calf serum, 100 U/ml
penicillin and 0.1 mg/ml streptomycin. Cells were passaged twice
weekly. Transfection of the cells was carried out as follows.
Coverslips in live cell dishes (MatTek, MA, USA) or in 6- or 24-
well plates were seeded with ,3610
5 cells/ml media, and cells
Analysis of NCS-1 Mutant
PLoS ONE | www.plosone.org 11 May 2010 | Volume 5 | Issue 5 | e10534were allowed to adhere overnight. Transfection mixes were made
up with 3 ml of the Gene Juice reagent (Novagen, Prudhoe, UK)
per mg plasmid in 100 ml Optimem 1 (Gibco), incubated for 30
minutes, and then applied to cells. Cells were incubated for a
further 18 hours prior to experiments. Cells expressing VSVG-
GFP were incubated for 18 h at 20uC and then washed in PBS
and fixed in 4% (v/v) paraformaldehyde for 30 min prior to
imaging. All other imaging was carried out on live cells.
Western blotting
Cell lysates were made by direct addition of 200 ml/well
Laemmlli buffer (Sigma) to cells in 6-well plates following washing
with PBS. Samples were resolved using SDS-PAGE (12.5% gels)
and transferred to nitrocellulose filters for Western blotting by
transverse electrophoresis. Anti-NCS-1 (Transduction Laborato-
ries, Oxford, UK), anti-IL1RAPL1 (AbCam, Cambridge, UK)
and anti-GFP (JL-8) (Clontech) were used at 1:800, 1:200 and
1:1000 dilutions respectively. HRP-conjugated secondary antibod-
ies (Sigma) were used at a 1:400 dilution, and blots were analysed
by detection of chemiluminescence using a Biorad Chemidoc XRS
system (Biorad, Hemel Hempstead, UK).
Confocal fluorescence microscopy
Confocal microscopy following fixation, in live cell single-frame
imaging and in calcium indicator experiments, was carried out on
a Leica TCS-SP2 microscope (Leica Microsystems, Heidelberg,
Germany) using a 63x oil-immersion objective with a 1.4
numerical aperture. The pinhole was set to airy2 for calcium
indicator experiments and to airy1 for all other experiments.
Fluorescence loss in photobleaching (FLIP) and fluorescence
recovery after photobleaching (FRAP) experiments were carried
out on a Leica TCS-SP2-MP microscope (Leica Microsystems). A
63x water-immersion objective with a 1.2 numerical aperture was
used and the pinhole set to airy 2.06. Where variant GFP-
containing constructs were used, wells/dishes were transfected
with 0.5 mg of each plasmid. ECFP-, EGFP-, and mCherry-
containing constructs were excited using 405 nm, 488 nm and
594 nm lasers respectively, and emitted light was collected
between 450–500 nm, 500–550 nm and 625–675 nm. Fluo-4
was excited using a 488 nm laser, and emitted light was collected
between 495–545 nm. Golgi-YFP was excited using a 514 nm
laser, and emitted light was collected between 530–600 nm. All
imaging of live cells and was carried out on cells at room
temperature in Krebs Ringer buffer (145 mM NaCl, 20 mM
HEPES, 10 mM Glucose, 5 mM KCl, 1.3 mM MgCl2, 1.2 mM
NaH2PO4).
In calcium indicator experiments, cells were loaded with 5 mM
Fluo-4-AM (Invitrogen) for 30 minutes at room temperature to
allow measurement of changes in [Ca
2+]i. Equal numbers of
untransfected and transfected cells were analysed in each field, and
following background-subtraction using Image J software (NIH),
Fluo-4 fluorescence measurements for each cell were normalised
with respect to fluorescence at the first time-point.
In FLIP experiments, rectangular regions of interest (ROIs),
4 mmb y2mm, in the cytosol of cells, were repetitively bleached
using 75% of laser power. To discriminate fluorescence loss in
different cellular regions, background fluorescence was subtracted
from images and ROIs drawn around the outside perimeter, inside
perimeter, nucleus, and Golgi of cells. Values for average plasma
membrane pixel intensity were calculated after subtracting
fluorescence totals and pixel number contained by the inner
perimeter from those contained by the outer perimeter. Values for
average cytosol pixel intensity were calculated after subtracting
fluorescence totals and pixel numbers contained by the nucleus,
Golgi and bleached region from those contained by the inner
perimeter. Data was normalised with respect to fluorescence of
adjacent cells in each experiment in order to correct for bleaching
during low power laser excitation.
In FRAP experiments, circular regions of interest of diameter
2 mm, were bleached using 75% of laser power following prior
capture of 10 frames. 100 post-bleach frames were recorded per
cell. To determine the rate of fluorescence recovery, fluorescence
in these regions was measured over time, and then normalised
with respect to corresponding total cellular fluorescence at each
individual time point to correct for bleaching during low power
laser excitation. Bleaching experiments with NCS-1-EGFP and
NCS-1(R102Q)-EGFP, and experiments in the presence and
absence of thapsigargin, were conducted in parallel. Non-linear
regression analysis was used to calculate the rate and extent of
fluorescence recovery of each construct and was carried out using
Graphpad Prism software (Graphpad software, CA, USA).
Supporting Information
Figure S1 Coomassie Blue-stained SDS-gel used for quantifica-
tion of NCS-1 and NCS-1(R102Q) binding to GST-IL1-
RAPL1(569-644). Each gel has 4 independent binding assays on
the left, carried out at 1 mM free Ca
2+ concentration, and four
lanes of the input NCS-1 protein on the right.
Found at: doi:10.1371/journal.pone.0010534.s001 (5.82 MB TIF)
Figure S2 IL1RAPL1 and NCS-1 are endogenously expressed
by N2A cells. A. Samples of N2A cells were separated by SDS-
PAGE, prepared for Western blotting and probed with antisera
specific for IL1RAPL1 or NCS-1 as indicated. B-D N2A cells were
fixed and processed for immunufluorescence staining with anti-
NCS-1 and anti-IL1RAPL1. The overlay shows anti-IL1RAPL1
in green and anti-NCS-1 in red with co-localisation in yellow in
the overlay image.
Found at: doi:10.1371/journal.pone.0010534.s002 (3.37 MB TIF)
Table S1 Propensity of helix formation predicted by use of
Agadir (reference 48).
Found at: doi:10.1371/journal.pone.0010534.s003 (0.09 MB TIF)
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